Diametric Capital, LP Arcturus Therapeutics Holdings Inc. Transaction History

Diametric Capital, LP

$205 Million
Q3 2025

A detailed history of Diametric Capital, LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Diametric Capital, LP holds 20,786 shares of ARCT stock, worth $151,114. This represents 0.19% of its overall portfolio holdings.

Number of Shares

20,786

Previous 59,195 64.89%

Holding current value

$151,114

Previous $770,000 50.26%

% of portfolio

0.19%

Previous 0.51%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$11.39 - $22.17 $437,478 - $851,527	-38,409 Reduced 64.89%	20,786 $383,000
Q2 2025 Aug 13, 2025	BUY	$8.91 - $14.41 $414,929 - $671,059	46,569 Added 368.83%	59,195 $770,000
Q1 2025 May 14, 2025	BUY	$10.59 - $20.83 $133,709 - $262,999	12,626 New	12,626 $133,000
Q3 2024 Nov 13, 2024	BUY	$18.08 - $25.38 $24,172 - $33,933	1,337 Added 4.08%	34,102 $791,000
Q2 2024 Aug 13, 2024	BUY	$24.35 - $44.39 $481,302 - $877,412	19,766 Added 152.06%	32,765 $797,000

Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $434,690 - $598,377	-13,919 Reduced 51.71%	12,999 $438,000
Q4 2023 Feb 13, 2024	BUY	$17.71 - $32.97 $13,955 - $25,980	788 Added 3.02%	26,918 $848,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $123,536 - $181,371	4,856 Added 22.83%	26,130 $667,000
Q2 2023 Aug 11, 2023	SELL	$23.94 - $32.36 $260,826 - $352,562	-10,895 Reduced 33.87%	21,274 $610,000
Q1 2023 May 11, 2023	BUY	$14.72 - $23.97 $473,527 - $771,090	32,169 New	32,169 $771,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $275,837 - $701,293	22,499 New	22,499 $354,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $180,576 - $251,116	-5,280 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $31,699 - $66,230	-1,137 Reduced 17.72%	5,280 $252,000
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $165,494 - $270,219	6,417 New	6,417 $217,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $354,683 - $1.27 Million	-10,248 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $46,112 - $77,723	-1,230 Reduced 10.72%	10,248 $440,000
Q2 2020 Aug 14, 2020	SELL	$12.66 - $58.27 $500,614 - $2.3 Million	-39,543 Reduced 77.5%	11,478 $536,000
Q1 2020 May 15, 2020	SELL	$9.31 - $18.26 $8,946 - $17,547	-961 Reduced 1.85%	51,021 $693,000
Q4 2019 Feb 14, 2020	BUY	$8.93 - $12.41 $120,742 - $167,795	13,521 Added 35.16%	51,982 $565,000
Q3 2019 Nov 13, 2019	BUY	$8.8 - $14.5 $2,235 - $3,683	254 Added 0.66%	38,461 $395,000
Q2 2019 Aug 14, 2019	BUY	$5.78 - $9.79 $220,836 - $374,046	38,207 New	38,207 $361,000

Others Institutions Holding ARCT

# of Institutions

173

Shares Held

26M

Call Options Held

2.32M

Put Options Held

866K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $193M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Account

Diametric Capital, LP Arcturus Therapeutics Holdings Inc. Transaction History